argenx SE - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARGX Nasdaq 2836 argenx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for argenx SE

argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run - Oct 10th, 2026 6:18 am
argenx Meets Primary Endpoint in Phase II Celiac Disease Study - Oct 9th, 2026 10:55 am
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week - Oct 9th, 2026 9:15 am
ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Study - Oct 9th, 2026 6:31 am
argenx (ENXTBR:ARGX) Gets Mixed Trial News, Is It Still Overvalued? - Oct 9th, 2026 6:13 am
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial - Oct 8th, 2026 3:03 pm
Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's - Oct 8th, 2026 2:21 pm
Sector Update: Healthcare Stocks Softer Late Afternoon - Oct 8th, 2026 1:53 pm
IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class - Oct 8th, 2026 11:33 am
Argenx Stock Sinks on Scrapped Autoimmune Drug Trial. Why the Selloff Is Overdone. - Oct 8th, 2026 11:23 am
HALO Wins Court Order Blocking Merck's Keytruda SC in Europe - Oct 8th, 2026 9:46 am
argenx shares drop after trial of Vyvgart in Sjögren's disease is halted - Oct 8th, 2026 9:41 am
Argenx falls as Sjögren’s setback offsets celiac drug progress - Oct 8th, 2026 9:38 am
argenx Gets a Painful Reality Check in Sjögren’s - Oct 8th, 2026 9:08 am
European Equities Traded in US as ADRs Fall in Thursday Trading - Oct 8th, 2026 9:05 am
argenx Reports Positive Phase 2 Celiac Disease Trial Results, Plans Phase 3 Development of FB102 - Oct 8th, 2026 8:35 am
Argenx Sinks 11% as Sjogren’s Trial Halted for Futility: “Disappointed by This Outcome” - Oct 8th, 2026 7:33 am
Why Is ARGX Stock Plunging Today? - Oct 8th, 2026 6:19 am
Argenx Halts Phase 3 Study in Rare Disease Following Futility Analysis - Oct 8th, 2026 6:13 am
Argenx cans Phase III Vyvgart Sjögren’s study on predicted efficacy fail - Oct 8th, 2026 5:45 am